Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases
International Journal of Dermatology · 2023
DOI: 10.1111/ijd.16698 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Dermatology, 2023. Verfasst von Juan Bai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Skin Diseases, Amyloidosis, Lichenoid Eruptions. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Health Science and Technology Project of Health Commission of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
ORCID-Profile: Jianjun Qiao
Förderung
- Health Science and Technology Project of Health Commission of Zhejiang Province
Zitieren
APA
Bai, J., Su, W., Fang, H., & Qiao, J. (2023). Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases. International Journal of Dermatology. https://doi.org/10.1111/ijd.16698
Vancouver
Bai J, Su W, Fang H, Qiao J. Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases. International Journal of Dermatology. 2023. doi:10.1111/ijd.16698
BibTeX
@article{Bai2023,
author = {Bai, Juan and Su, Wang and Fang, Hong and Qiao, Jianjun},
title = {Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases},
journal = {International Journal of Dermatology},
year = {2023},
doi = {10.1111/ijd.16698}
}
EUVIMED